#NephJC number 10, by the numbers:
Dare I say that last night was the best #NephJC yet?
Wow! What a great discussion!
We had 22 participants, including a number of new faces. This is the highest participation since we teamed with the cardiologists for POSEIDON in NephJC #5. The people also participated with 308 tweets, also the second most, next to POSEIDON, ever. Great #NephJC. Thank you everyone.
Here are the numbers and links to the analytics and transcript.
#NephJC goes again tonight at 9pm
We are going to discuss the intriguing article on pentoxifilline for diabetic kidney disease. Take a look at the summary on NephJC or the comprehensive summary of renal studies of pentoxifilline written by Christos Argyropoulos at Precious Bodily Fluids.
This is our 11th NephJC. Hope to see everyone there!
What is #NephJC Live?
So this is the obvious question. The idea is still not fully formed but the pitch to ASN was that we would find some scientists who are presenting at an ASN poster session that would like a venue to discuss their data in front of an intelligent, engaged and honestly, quite handsome audience. The NephJC Live session is on Saturday, so everybody's embargo will be expired and authors will be free discuss their research.
That said we are looking for scientists eager to present at NephJC. If you are interested or know someone with great data that did not get an opportunity to discuss it with an oral presentation have them contact nephrologyjc@gmail.com.
#NephJC is going to do a live show at #KidneyWk14
We just got approval from the powers at ASN to do a live session on Saturday. We plan on having lunch and discussing a couple of studies but the real attraction will be meeting people face to face. More details as they become finalized!
CJASN eJC goes to Twitter
This month eJC is talking about Nephrology Fellowship. The article they are using is here and was written by Jeffrey Barns, Stuart Linas and Mitchell Rosner.
As part of the discussion eJC did their first TweetChat on September 10th. It was great, with an excellent turn-out and spirited discussion. Nephrology fellow Amar Bansal lead the discussion. NephJC produced a curated transcript with Storify. Here it is:
Official record of the sodium excretion, blood pressure and mortality tweet chat
The next NephJC on Tuesday September 9th goes to sodium land
We will be discussing the 3 articles on sodium excretion, hypertension and mortality that were published in the NEJM on August 14 at 9pm. PBFluids has an early summary. Look for more background and links in the coming days.
Storify of Tuesday's TwitterChat
Tejas Desai of Nephrology On-Demand curated the chat into a tight Storify.
NephJC #9 is in the can
Great tweet chat tonight. Here are the analytics and the transcript. Look for a curated (Storify) transcript in a day or two.
Tweet of the (last) Week
Every so often a single tweet neatly encompasses the entire discussion. This happened at last week's aPLA2R TweetChat. This is the tweet that won:
But to properly set it up you need to additional tweets:
I love the idea of aPLA2R as a viral load, a leading indicator of idiopathic membranous nephropathy. Nice work Christos. For your effort we will be sending you a #NephJC coffee mug.
Want your own NephJC coffee mug?
Tweet better!
Next opportunity is tonight 9pm Eastern.
The Storify overview of #NephJC 8: aPLA2R
Once again we have two curated archives of the discussion. Joel Topf just published his version for NephJC:
And Tejas of Nephrology On-Demand once again published his curation:
aPLA2R Tweetchat, by the numbers
The August 12 Tweetchat went well with broad participation.
Tonight's NephJC Tweetchat is all about aPLA2R
aPLA2R is the first blood test specifically for nephrotic syndrome. It has recently been licensed by the FDA and we want to have an open and frank discussion on how this test may be used in clinical medicine. To aid in this discussion we will be looking at two papers.
The first was highlighted by CJASN's eJC and was covered summarized by Joel Topf and his Fellow, Bilal Saleem:
- Article Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy
- eJC forum
- Background and Summary by Topf and Saleem
- Make sure you take a look at the Editorial by Glassock (available for free if you register with eJC)
- PDF slide show summary of the article and editorial
The second article was published this past Spring in NDT. It is an industry sponsored trial of ACTH for the treatment of membranous nephropathy. Swapnil Hiremath summarized it for #NephJC
- Article (#OpenAccess)
- Background by Hiremath
- PDF of summary
And additionally here is a link to the KDIGO Glomerulonephritis Recommendations.
Please join us on Twitter at 9pm Eastern Daylight. Use the hashtag #NephJC.
FOAMED Student blog covers Nephrology
Pubmed Commons comment up for Meso-American Nephropathy
A bit belatedly, the pubmed comment is up from the great discussion from July 8th on MesoAmerican Nephropathy here.
NephJC made the FOAM Reduction e-mail mailing list
FOAM Reduction bills itself as a Twitter-free means of receiving FOAM (free open access medical education). The July 25th edition touched on the recent hyponatremia guidelines and included a shout out to our TweetChat. We are honored.
“Hyponatremia
Rumor has it that hyponatremia is near the top of UpToDate’s most searched list. Probably because it is so damn common (15-20% of hospital admissions) and the algorithm is a pain. Enter the Hyponatremia Guideline Development Group (I want to party with these guys), who recently published a new clinical practice guideline for diagnosis and treatment of hyponatremia. It is surprisingly easy to follow, by eliminating volume status guesses and depending on urine osmolality, urine sodium to determine the etiology of water excess.
The guideline can be found here and if you want a more expert take on the guidelines, a group of nephrologists performed a Twitter-based journal club (#NephJC, @nephjc) dissection on the guideline here.
I included the diagnosis algorithm from the new guideline below, along with the algorithm I see used most often.”
Storify of our RIVUR trip
RIVUR Tweetchat analytics
Our newsletter just went out and it is a doozy
Did we mention we had a news letter? (please sign up)
If you were on the mailing list, you can see the letter here. The e-mail covers three important pieces of NephJC news
1
Our next TweetChat is next Tuesday at 9 PM. We are looking at the NEJM article about VUR prophylaxis. Interesting paper. Pascal Lane did a wonderful summary of the study.
2
We are changing the way we do video interviews. These will no longer be scheduled events but, instead will get done when we can arrange a time with the most interesting scientists willing to talk to us.
3
We are exploring the possibility of doing a Live NephJC during Kidney Week in Philadelphia. We have a four question Survey Monkey to try to gauge how much interest there is in this idea.